Mark Sampson, Chief Medical Officer at Shield Therapeutics, holds 83.70K shares in Shield Therapeutics (Ticker: GB:STX). Most recently, Mark Sampson Bought 44,917p shares of Shield Therapeutics on Apr 27, 2019 for an estimated value of 39.99K.
What is the percentage of profitable transactions made by Mark Sampson?
The percentage of profitable transactions made by Mark Sampson is ―.
What is the average return per transaction made by Mark Sampson?
The average return per transaction made by Mark Sampson is ―.
What stocks does Mark Sampson hold?
Mark Sampson holds: GB:STX stocks.
What was Mark Sampson’s latest transaction?
Mark Sampson latest transaction was an Informative Buy of 39.99K.
What was Mark Sampson's most profitable transaction?
Mark Sampson’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Mark Sampson's role in Shield Therapeutics?
Mark Sampson's role in Shield Therapeutics is Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.